Galenfeha, Inc. financials

NGHI CIK 0001574676

Source: EDGAR filings · Built 2026-06-19T01:18:19Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014
Free Cash Flow -393.21K -1.42M -859.08K -139.13K
EBITDA -94.92K -571.94K -416.34K -445.24K -135.71K
Working Capital -67.41K -11.29K 443.73K 139.69K 77.00K
Net Debt 26.90K -129.97K 148.44K -75.41K -73.48K
Gross Margin 23.71%
Operating Margin -161.73%
Net Margin -169.26%
Return on Equity (ROE) 241.15% 12458.20% -153.95% -125.64% -156.34%
Return on Assets (ROA) -295.78% -243.65% -93.48% -79.18% -147.59%
Current Ratio 0.45× 0.98× 1.66× 1.68× 15.86×
Debt-to-Equity -0.41× 0.00× 0.19× 0.05× 0.00×
Effective Tax Rate 0.00%
Cash Conversion Ratio 0.60× 0.31× 0.84× 1.42× 0.96×
Accruals Ratio -1.19× -1.69× -0.15× 0.33× -0.06×
CapEx Coverage -18.44× -3.57× -15.59×
Free Cash Flow Per Share $-0.00 $-0.02 $-0.01 $-0.00

Income Statement

Concept FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014
Revenues 280.06K 0
Cost of Revenue 958.60K 213.66K 0
Gross Profit 331.68K 66.40K 0
Research and Development Expense 3.79K 0 174.47K 58.85K 12.26K
Operating Expenses 94.92K 597.65K 440.73K 519.36K 136.53K
Operating Income (Loss) -94.92K -597.65K -440.73K -452.96K -136.53K
Income Tax Expense (Benefit) 0
Net Income (Loss) Attributable to Parent -162.57K -1.28M -1.60M -474.02K -136.50K

Balance Sheet

Concept FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014
Cash and Cash Equivalents, at Carrying Value 469 129.97K
Assets, Current 54.96K 525.20K 1.12M 346.55K 82.17K
Assets 54.96K 526.20K 1.71M 598.66K 92.48K
Long-term Debt 1.64M
Liabilities, Current 122.38K 536.49K 672.07K 206.86K 5.18K
Long-term Debt, Excluding Current Maturities 0 14.52K 0
Liabilities 122.38K 536.49K 672.07K 221.38K 5.18K
Stockholders' Equity Attributable to Parent -67.41K -10.29K 1.04M 377.28K 87.31K
Common Stock, Shares, Outstanding 72.30M 72.30M 69.32M 86.13M 77.81M 51.25M

Cash Flow Statement

Concept FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014
Net Cash Provided by (Used in) Operating Activities -97.32K -393.21K -1.35M -671.17K -130.74K
Payments to Acquire Property, Plant, and Equipment 0 73.08K 187.92K 8.39K
Net Cash Provided by (Used in) Investing Activities -19.51K 350.00K -228.38K -248.92K -8.39K
Payments for Repurchase of Common Stock 677 0
Net Cash Provided by (Used in) Financing Activities -12.67K 125.85K 1.53M 941.27K 212.60K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (NGHI CIK 0001574676), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

INFU

InfuSystem Holdings, Inc.

SCNI

SCINAI IMMUNOTHERAPEUTICS LTD.

BHM

BLUEROCK HOMES TRUST, INC.